Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 1999

View Archived Issues

York Medical: Annual Report 1998

U.S. patent issues to Washington University for mammaglobin

Steroidogenesis Inhibitors to begin satellite open clinical studies in multiple indications

Synvisc relieves pain, delays need for total knee replacement in osteoarthritis

Cubist enters agreement with Novartis for antiinfective drug discovery

Pierre Fabre Dermatologie to commercialize Allergan's Zorac in Europe

Positive preclinical results for NuChem's anticancer compounds in lung cancer model

InSite Vision updates shareholders

PSP94 suppresses prostate cancer growth in mouse model

Rosetta and Acacia announce intention to merge

Abbott makes milestone payments to Aronex for antifungal drug Nyotran

Orally bioavailable tachykinin antagonists from MS&D for emesis, etc.

Biota's flu drug gets first approval

Astra describes N-type neuronal calcium channel blockers and their use

Good safety, increased immunogenicity reported for MF59-adjuvanted flu vaccine

Neurogen and Pfizer collaborate on development of NPY receptor ligands

New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level

New compounds from Novo Nordisk for pain, inflammation, diabetes

Kanebo to be acquired by Organon, merged into Nippon Organon

Mitsubishi antidepressant to be codeveloped by Taisho

Glaxo presents new NNRTI from quinoxaline class that has progressed to human trials

T-140, a potent CXCR4-dependent inhibitor of HIV infection

Pediatric study supports use of vCP205 in infants born to HIV-positive mothers

Bristol-Myers Squibb suspends clinical studies of lobucavir

Celebrex receives approval in Mexico

Broad patent issues for Avigen's AAV vectors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...